ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
26 Nov 2020

FDA identifies exclusive code for the CADScor®

Press release (MAR)Malmö, Sweden, November 26, 2020 FDA identifies exclusive code for the CADScor® After yesterday’s a...
Continue reading
author-avatar acarix
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory
November 18, 2024
25 Nov 2020

Acarix receives US market approval for the CADScor® System

Press release (MAR)Malmö, Sweden November 25, 2020 Acarix receives US market approval for the CADScor® System Acarix AB (pu...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
18 Nov 2020

Positive results from Acarix study presented at ISPOR, a leading health economics conference

Press releaseMalmö, Sweden November 18, 2020 Positive results from Acarix study presented at ISPOR, a leading health economics co...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
12 Nov 2020

Correction: Interim report 2020-01-01 to 2020-09-30

Press release (MAR) Malmö, November 12, 2020 Correction: Interim report 2020-01-01 to 2020-09-30 In the interim report that Ac...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
12 Nov 2020

A Successful Rights Issue with Focus on Sales!

Press release (MAR) Malmö, November 12, 2020 Acarix AB (publ) publishes Interim Report, January – September 2020 A Success...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
15 Oct 2020

Acarix changes Certified Advisor to Redeye

  Press release Malmö, Sweden October 15, 2020 Acarix changes Certified Advisor to Redeye Acarix AB (publ) announces t...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
29 Sep 2020

Acarix carries out a directed issue of shares to guarantors in conjunction with the oversubscribed rights issue

Press release Malmö, Sweden September 29, 2020 Acarix carries out a directed issue of shares to guarantors in conjunction with th...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Other, Regulatory
November 18, 2024
28 Sep 2020

Last day of trading in paid subscribed shares (Sw. BTA)

Press release Malmö, Sweden September 28, 2020 Last day of trading in paid subscribed shares (Sw. BTA) Last day of trading in su...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
11 Sep 2020

Acarix announce final outcome in oversubscribed rights issue

Press release Malmö, Sweden September 11, 2020 Acarix announce final outcome in oversubscribed rights issue Acarix AB ("Acarix"...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
09 Sep 2020

Acarix announces preliminary outcome in oversubscribed rights issue

Press release Malmö, Sweden September 9, 2020 Acarix announces preliminary outcome in oversubscribed rights issue INSIDE INFORMA...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Prospectus, Regulatory
November 18, 2024
03 Sep 2020

Acarix publishes a supplement to the prospectus

  Press releaseMalmö, Sweden September 3, 2020 Acarix publishes a supplement to the prospectus The board of directors of A...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
03 Sep 2020

Acarix progresses with the German authorities

Press releaseMalmö, Sweden September 3, 2020 Acarix progresses with the German authorities Acarix AB (publ) today announced...
Continue reading
  • «
  • ‹
  • 13
  • 14
  • 15
  • 16
  • 17
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.